Ignite Creation Date:
2025-12-24 @ 11:49 PM
Ignite Modification Date:
2025-12-25 @ 9:43 PM
Study NCT ID:
NCT01513551
Status:
COMPLETED
Last Update Posted:
2018-12-13
First Post:
2011-12-27
Is NOT Gene Therapy:
False
Has Adverse Events:
True
Brief Title:
The Safety, Tolerability, and Immunogenicity Profiles of a Single Dose of V114, PNEUMOVAX® 23, or PREVNAR 13® in Adults 50 Years of Age or Older (V114-002)
Sponsor:
Merck Sharp & Dohme LLC